SIP sigma pharmaceuticals limited

worth a look, page-2

  1. LZA
    1,858 Posts.
    annual report not impressed by headline figures personally as it includes amalgamation, the bottom line is eps which is only 5.1c, giving a pe of 24 which is too high for a low growth stock at this stage.

    cant see the high previous growth of Arrow continuing, its going to become a yield play, but the 3.6c div is not enough for me.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.